Hepatic hemodynamics and cell functions in human and experimental sepsis

Anesthesia and Analgesia

Volumn 89, Issue 2, 1999, Pages 344-352

  Pastor, Catherine M ^a   Suter, Peter M ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; ENDOTOXIN; INDOCYANINE GREEN; LACTATE DEHYDROGENASE; LACTIC ACID; OXYGEN;

ARTICLE; CELL FUNCTION; HEMODYNAMICS; HUMAN; KUPFFER CELL; LIVER BLOOD FLOW; LIVER CELL; LIVER INJURY; MULTIPLE ORGAN FAILURE; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SPLANCHNIC BLOOD FLOW;

EID: 0032802130     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199908000-00019     Document Type: Article

References (94)

1. Mathison JC, Ulevitch RJ. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979;123:2133-43.
2. Mimura Y, Sakisaka S, Harada M, et al. Role of hepatocytes in direct clearance of lipolysaccharide in rats. Gastroenterology 1995;109:1969-76.
3. Katz S, Jimenez MA, Lehmkuhler WE, et al. Liver bacterial clearance following hepatic artery ligation and portacaval shunt. J Surg Res 1991;51:267-70.
4. Alcorn JM, Fierer J, Chojkier M. The acute-phase response protects mice from D- galactosamine sensitization to endotoxin and tumor necrosis factor-a. Hepatology 1992;15:122-9.
5. Vary TC, Kimball SC. Regulation of hepatic protein synthesis in chronic inflammation and sepsis. Am J Physiol 1992;262: C445-52.
6. Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991;13:364-75.
7. Bradley EL. Measurement of hepatic blood flow in man. Surgery 1974;75:783-9.
8. Johnson DJ, Muhlbacher F, Wilmore DW. Measurement of hepatic blood flow. J Surg Res 1985;39:470-81.
9. McDougal WS, Heimburger S, Wilmore DW, et al. The effect of exogenous substrate on hepatic metabolism and membrane transport during endotoxemia. Surgery 1978;84:55-61.
10. Reinelt H, Radermacher P, Fischer G, et al. Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 1997;86: 818-24.
11. Villeneuve JP, Huot R, Marleau D, et al. The estimation of hepatic blood flow with indocyanine green: comparison between the continuous infusion and single injection methods. Am J Gastroenterol 1982;77:233-7.
12. Fong Y, Marano MA, Moldawer LL, et al. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 1990;85:1896-904.
13. Ruokonen E, Takala J, Kari A, et al. Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993;21: 1296-303.
14. Dahn MS, Lange P, Lobdell K, et al. Splanchnic and total body oxygen consumption differences in septic and injured patients. Surgery 1987;101:69-80.
15. Takala J. Determinants of splanchnic blood flow. Br J Anaesth 1996;77:50-8.
16. Meier-Hellmann A, Specht M, Hannemann L, et al. Splanchnic blood flow is greater in septic shock treated with norepinephrine than in severe sepsis. Intensive Care Med 1996;22:1354-9.
17. Mitolo-Chieppa D, Serio M, Potenza MA, et al. Hyporeactivity of mesenteric vascular bed in endotoxin-treated rats. Eur J Pharmacol 1996;309:175-82.
18. Santak B, Radermacher P, Adler J, et al. Effect of increased cardiac output on liver blood flow, oxygen exchange and metabolic rate during longterm endotoxin-induced shock in pigs. Br J Pharmacol 1998;124:1689-97.
19. Saetre T, Gundersen Y, Smiseth OA, et al. Hepatic oxygen metabolism in porcine endotoxemia: the effect of nitric oxide synthase inhibition. Am J Physiol 1998;275:G1377-85.
20. Dahn MS, Mitchell RA, Lange MP, et al. Hepatic metabolic response to injury and sepsis. Surgery 1995;117:520-30.
21. Russel JA, Phang PT. The oxygen delivery/consumption controversy: approaches to management of the critically ill. Am J Resp Crit Care Med 1994;149:533-7.
22. Steffes CP, Dahn MS, Lange MP. Oxygen transport-dependent splanchnic metabolism in the sepsis syndrome. Arch Surg 1994; 129:46-52.
23. 2 dependency exists in critically ill septic patients? Am J Resp Crit Care Med 1998;157:1219-25.
24. Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock 1998;9:1-11.
25. Fink MP, Heard SO. Laboratory models of sepsis and septic shock. J Surg Res 1990;49:186-96.
26. Michie HR. The value of animal models in the development of new drugs for the treatment of the sepsis syndrome. J Antimicrob Chemother 1998;41(Suppl A):47-9.
27. Muller W, Smith LL. Hepatic circulatory changes following endotoxin shock in the dog. Am J Physiol 1963;204:641-4.
28. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48-57.
29. Pastor CM, Payen DM. Effect of modifying nitric oxide pathway on liver circulation in a rabbit endotoxin shock model. Shock 1994;2:196-202.
30. Schiffer ERC, Mentha G, Schwieger IM, et al. Sequential changes in the splanchnic circulation during continuous endotoxin infusion in sedated sheep: evidence for a selective increase of hepatic artery blood flow and loss of the hepatic arterial buffer response. Acta Physiol Scand 1993;147:251-61.
31. Lautt WW. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 1985;249:G549-56.
32. Lautt WW, McQuaker JE. Maintenance of hepatic arterial blood flow during hemorrhage is mediated by adenosine. Can J Physiol Pharmacol 1989;67:1023-8.
33. Ayuse T, Brienza N, Revelly JP, et al. Alterations in liver hemodynamics in an intact porcine model of endotoxin shock. Am J Physiol 1995;268:H1106-14.
34. Hinshaw LB, Reins DA, Hill RJ. Response of isolated liver to endotoxin. Can J Physiol Pharmacol 1966;44:529-41.
35. Goris KJA, Boekhorst TPA, Nuytinck JKS, et al. Multiple organ failure: generalized autodestructive inflammation? Arch Surg 1985;120:1109-15.
36. Le Gall J-R, Klar J, Lemeshow S, et al. The logistic organ dysfunction system: a new way to assess organ dysfunction in the intensive care unit. JAMA 1996;276:802-10.
37. Smail N, Messiah A, Edouard A, et al. Role of systemic inflammatory response syndrome and infection in the occurrence of early multiple organ dysfunction syndrome following severe trauma. Intensive Care Med 1995;21:813-6.
38. Maynard ND, Bihari DJ, Dalton RN, et al. Liver function and splanchnic ischemia in critically ill patients. Chest 1997;111: 180-7.
39. Fry DE, Pearlstein L, Fulton RL, et al. Multiple system organ failure: the role of uncontrolled infection. Arch Surg 1980;115: 136-40.
40. Hebert PC, Drummond AJ, Singer J, et al. A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 1993;104:230-5.
41. Fagon J-Y, Chastre J, Novara A, et al. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med 1993;19:137-44.
42. Bone RC, Balk R, Slotman G, et al. Adult respiratory distress syndrome: sequence and importance of development of multiple organ failure. Chest 1992;101:320-6.
43. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. JAMA 1995;274:968-74.
44. Goldfarb G, Nouel O, Poynard T, et al. Efficiency of respiratory assistance in cirrhotic patients with liver failure. Intensive Care Med 1983;9:271-3.
45. Hewett JA, Roth RA. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev 1993;45:381-411.
46. Pastor CM, Billiar TR, Losser M-R, et al. Liver injury during sepsis. J Crit Care 1995;10:183-97.
47. Wang P, Chaudry IH. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol 1996;270:R927-38.
48. Crawford JM. Cellular and molecular biology of the inflamed liver. Curr Opin Gastroenterol 1997;13:175-85.
49. Inoue Y, Pacitti AJ, Souba WW. Endotoxin increases hepatic glutamine transport activity. J Surg Res 1993;54:393-400.
50. Inoue Y, Bode BP, Beck DJ, et al. Arginine transport in human liver: characterization and effects of nitric oxide synthase inhibitors. Ann Surg 1993;218:350-63.
51. Ohtake Y, Clemens MG. Interrelation between hepatic ureagenesis and gluconeogenesis in early sepsis. Am J Physiol 1991;260: E453-8.
52. Casteleijn E, Kuiper J, Van Rooij HCJ, et al. Endotoxin stimlates glycogenolysis in the liver by means of intercellular communication. J Biol Chem 1988;263:6953-5.
53. Hill M, McCallum R. Altered transcription regulation of phosphoenolpyruvate carboxykinase in rats following endotoxin treatment. J Clin Invest 1991;88:811-6.
54. Apantaku FO, Foe LG, Schumer W, et al. Hepatic fructose 2,6-biphosphate in rats with peritonitis and septic shock. Surgery 1984;96:770-3.
55. Orlinska U, Newton RC. Role of glucose in interleukin-1β production by lipopolysaccharide-activated human monocytes. J Cell Physiol 1993;157:201-8.
56. Abdel-Razzak Z, Loyer P, Fautrel A, et al. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 1993;44:707-15.
57. Müller CM, Scierka A, Stiller RL, et al. Nitric oxide mediates hepatic cytochrome P450 dysfunction induced by endotoxin. Anesthesiology 1996;84:1435-42.
58. Moseley RH. Sepsis-associated cholestasis. Gastroenterology 1997;112:302-6.
59. Decamp MM, Warner AE, Molina RM, et al. Hepatic versus pulmonary uptake of particles injected into the portal circulation: endotoxin escapes hepatic clearance causing pulmonary inflammation. Am Rev Respir Dis 1992;146:224-31.
60. Wang XD, Soltesz V, Andersson R, et al. Bacterial translocation in acute liver failure induced by 90 per cent hepatectomy in the rat. Br J Surg 1993;80:66-71.
61. McGuinness OP, Lacy DB, Ejiofor J, et al. Hepatic release of tumor necrosis factor in the endotoxin-treated conscious dog. Shock 1996;5:344-8.
62. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990;192:245-61.
63. Wang P, Ba ZF, Chaudry IH. Mechanism of hepatocellular dysfunction during early sepsis. Arch Surg 1997;132:364-70.
64. Ulich TR, Guo K, Yin S, et al. Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1α/β and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation. Am J Pathol 1992;141:61-8.
65. Bautista AP, Mészaros K, Bojta J, et al. Superoxide anion generation in the liver during the early stage of endotoxemia in rats. J Leukoc Biol 1990;48:123-8.
66. Mészaros K, Bojta J, Bautista AP, et al. Glucose utilisation by Kupffer cells, endothelial cells, and granulocytes in endotoxemic rat liver. Am J Physiol 1991;260:G7-12
67. Doi F, Goya T, Torisu M. Potential role of hepatic macrophages in neutrophil-mediated liver injury in rats with sepsis. Hepatology 1993;17:1086-94.
68. Jaeschke H, Smith CW. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 1997;61:647-53.
69. Jaeschke H. Cellular adhesion molecules: regulation and functional significance in the pathogenesis of liver diseases. Am J Physiol 1997;273:G602-11.
70. Chosay JG, Essani NA, Dunn CJ, et al. Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. Am J Physiol 1997;272:G1195-200.
71. Jaeschke H, Farhood A, Smith CW. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol 1991;261:G1051-6.
72. Bautista AP, Spolarics Z, Jaeschke H, et al. Monoclonal antibody against the CD18 adhesion molecule stimulates glucose uptake by the liver and hepatic nonparenchymal cells. Hepatology 1993;17:924-31.
73. ω-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 1990;48:565-9.
74. Harbrecht BG, Billiar TR, Stadler J, et al. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leuk Biol 1992; 52:390-4.
75. Bohlinger I, Leist M, Barsig J, et al. Interleukin-1 and nitric oxide protect against tumor necrosis factor α-induced liver injury through distinct pathways. Hepatology 1995;22:1829-37.
76. Thiermermann C, Ruetten H, Wu C-C, et al. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 1995;116:2845-51.
77. Ruetten H, Southan GJ, Abate A, et al. Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br J Pharmacol 1996;118:261-70.
78. Villa P, Demitri MT, Meazza C, et al. Effects of methyl palmitate on cytokine release, liver injury and survival in mice with sepsis. Eur Cytokine Netw 1996;7:765-9.
79. Pearson JM, Brown AP, Schultze AE, et al. Gadolinium chloride treatment attenuates hepatic platelet accumulation after lipopolysaccharide administration. Shock 1996;5:408-15.
80. Sarphie TG, D'Souza NB, Deaciuc IV. Kupffer cell inactivation prevents lipopolysaccharide-induced structural changes in the rat liver sinusoid: an electron-microscopic study. Hepatology 1996;23:788-96.
81. Vollmar B, Rüttinger D, Wanner GA, et al. Modulation of Kupffer cell activity by gadolinium chloride in endotoxemic rats. Shock 1996;6:434-41.
82. Libert C, Brouckaert P, Fiers W. Protection by α1-acid glycoprotein against tumor necrosis factor-induced lethality. J Exp Med 1994;180:1571-5.
83. Libert C, Van Molle W, Brouckaert P, et al. α1-antitrypsin inhibits the lethal response to TNF in mice. J Immunol 1996;157: 5126-9.
84. Louis H, Le Moine O, Peny M-O, et al. Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury. Gastroenterology 1997;112:935-42.
85. Wang P, Ayala A, Ba ZF, et al. Tumor necrosis factor-α produces hepatocellular dysfunction despite normal cardiac output and hepatic microcirculation. Am J Physiol 1993;265:G126-32.
86. Machiedo GW, Hurd T, Rush BF, et al. Temporal relationship of hepatocellular dysfunction and ischemia in sepsis. Arch Surg 1988;123:424-7.
87. Tran DD, Groeneveld ABJ, van der Meulen J, et al. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 1990;18:474-9.
88. Bakker J, Gris P, Coffernils M, et al. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg 1996;171:221-6.
89. Perl TM, Dvorak L, Hwang T, et al. Long-term survival and function after suspected Gram-negative sepsis. JAMA 1995;274: 338-45.
90. Carrico CJ, Meakins JL, Marshall JC, et al. Multiple-organ-failure syndrome. Arch Surg 1986;121:196-200.
91. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg 1992;216:117-34.
92. Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:1638-52.
93. Stevens LE. Gauging the severity of surgical sepsis. Arch Surg 1983;118:1190-2.
94. Vincent J-L, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med 1998;26:1793-800.